Last updated: June 2, 2026
TIVICAY PD suppliers: who manufactures and supplies dolutegravir pediatric dispersible tablets (PD)
TIVICAY PD is a dolutegravir dispersible pediatric formulation. Public manufacturing and supply information for this specific pediatric dosage form is not provided in the available prompt, so a complete supplier map cannot be produced without risking factual errors.
Who are the TIVICAY PD (dolutegravir) suppliers and contract manufacturers?
Answer: Unable to determine from the provided information.
Which roles matter for TIVICAY PD supply (API vs. finished dose)?
- Active pharmaceutical ingredient (API) dolutegravir suppliers
- Contract manufacturing organizations (CMOs) for tablet/dispersible tablet manufacturing
- Finished goods packagers (blistering, bottling, secondary packaging)
- Wholesalers and distribution partners
What companies supply dolutegravir dispersible tablets for children (TIVICAY PD)?
Answer: Unable to determine from the provided information.
Are suppliers different by region (US, EU, UK, LMIC markets)?
Answer: Unable to determine from the provided information.
What is the manufacturer of record for TIVICAY PD on labeling?
Answer: Unable to determine from the provided information.
How to verify quickly (labeling signals)
- “Manufactured for” / “Distributed by” lines on the prescribing information
- Country-of-origin and manufacturing site statements
- Package insert bottle/blister imprint codes
Which contract manufacturers make the dolutegravir pediatric dispersible formulation?
Answer: Unable to determine from the provided information.
Dosage-form-specific manufacturing constraints
- Dispersible tablet formulation handling
- Tablet uniformity and dissolution specifications
- Pediatric dose strength scaling vs. adult tablets
How does TIVICAY PD supply chain differ from adult TIVICAY (dolutegravir tablets)?
Answer: Unable to determine from the provided information.
Are the same sites used for adult and pediatric doses?
Answer: Unable to determine from the provided information.
Who supplies the dolutegravir API used in TIVICAY PD?
Answer: Unable to determine from the provided information.
API supply considerations that change the supplier landscape
- Multiple polymorph control
- Impurity profile and specification alignment
- Regulatory-authority qualification of API manufacturing sites
What are the main commercial risks to TIVICAY PD supply (single-site dependence, shortages)?
Answer: Unable to determine from the provided information.
Signals that affect shortage risk
- Monosource manufacturing
- Limited CMOs with dispersible tablet capacity
- Regulatory and lot-release bottlenecks
Key Takeaways
- A supplier and contract-manufacturer identification for TIVICAY PD cannot be completed using the information provided.
FAQs
- Is the API supplier for dolutegravir the same as the finished-dose manufacturer for TIVICAY PD?
Unable to determine from the provided information.
- Do TIVICAY PD suppliers change by country or tender market?
Unable to determine from the provided information.
- Is TIVICAY PD manufactured in the US or imported?
Unable to determine from the provided information.
- Who packages TIVICAY PD (blistering vs. bottles) for pediatric distribution?
Unable to determine from the provided information.
- Are there multiple manufacturing sites qualified for TIVICAY PD?
Unable to determine from the provided information.
References
No sources were provided in the prompt.
